Between 1900, the year of discovery of the ABO groups in man, and 1954, no clearly defined sub-groups of B had been described, whereas during the same period at least six sub-groups of A had been discovered and while the majority of A's were A1 or A2, rarer forms named A3, A4, A5, Ax, Az and Ao were shown to exist.
and B2 although the distinction could not be made as clearly as A1 and A2. At this stage the symbols B1 and B2 should not be con fused with the B antigen fractions B , B0 and 13,1i shown by Friedenreich 3) and others to ocour in all human B bloods tested, this differentiation being made by cross reactions with various animal sera. For distinction the 1 and 2 in the B sub-groups are in Arabic numerals, and for simplicity the B fractions will not be mentioned again.
In 1940 Hirszfed and Amzel 4) clasified group B bloods into two main groups, B1 and 132, with sub-divisions of B1 into B1", Br and B . This classification was made by titrations etc., with what we now call anti-H. This method did not give clear cut results and was not satisfaotory. Wiener 5) (1943) considered no work up to that time gave a practical method of subgrouping B bloods.
Between 1900 and 1955 in Europe and America, and particularly during the Second World War, many thousands of ABO blood groups were determined, but surprisingly it was not until 1954 that the first acceptable sub-group of B was described by Makela and Makela 6) . The red cells were weakly agglutinated by anti-B sera and the serum of the person with the weak B cells had a weak anti-B antibody, and B substances were present in the saliva. Giving Makela and Makela priority discounts the report of Formaggio 7) in 1953 of an AB person with anti-B in the serum. The reason for this is that a report will shortly be presented Ey Cameron and others8) of apparent AB people with anti-B in their sera, but no B substances in their saliva, and who have been shown to be genetically AO and to have acquired the B antigen. Formaggio 7) gave very brief details of his investigations and in the absence of :evidence of inheritance of this weak B antigen, Makela and Makela 6) are given priority.
The next report of a B sub-group was that of Moullec and co-authors 9) when they described the allele B3. The evidence presented included family study, absosptions and elutions. The cells gave feeble reations with anti-B, but surprisingly the saliva contained no B substances.
Following Moullec and others' report 9) of B3 came the report of Levine and co-workers 10) on -an even weaker form of B that could only be detected if the results of the reactions were read microscopically. Whilst B3 people did not secrete Bs ubstances, B, people did and differ at least in this respect. In the summary, Levine and workers 10) stated "the occurrence of other weak B's suggest a parallelism to the larger number of variants at the A locus". Further support came for this statement with the reports of Dunsford and others 11) (1956) and Yokoyama and others 12) (1957) of a sub-group of B, weaker than either B3 or av which they named Bx B, was chosen since this blood appeared to be the B allele corresponding to the A, described by Gammelgaard 13) although comparative studies have not been carried out it is probably a B similar to that described by Levine and others 10).
The second example also came from a Japanese family. In this study the B was stronger than the former case, but not as strong as normal B cells, 0 serum completely absorbed with   A1  cells  still  agglutinated  the  cells  and  this  reaction,  or  the  reaction  of  anti-B,  could  be   inhibited  by  the  addition  of  B  secretor  saliva,  but  not  by  A  and  0  secretor It will be observed that these theories were all suggested before the first sub-group of B had been found. Sub-groups of A had been well documented and could be classified, and the theories were built on these alone. 
